EMEA-002986-PIP01-21
Key facts
| Active substance |
Zorecimeran
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/0212/2021
|
| PIP number |
EMEA-002986-PIP01-21
|
| Pharmaceutical form(s) |
Concentrate and solvent for dispersion for injection
|
| Condition(s) / indication(s) |
Prevention of Coronavirus disease 2019 (COVID-19)
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
CureVac AG
Tel. +49 7071 9880-0 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|